Sector - Healthcare and Social Assistance

  1. A Checklist For Successful Medical Technology ...

    A Checklist For Successful Medical Technology ...

    Find an investment that will give your portfolio a shot in the arm.
  2. Investing In Health Insurance Companies

    Investing In Health Insurance Companies

    Health insurance companies work a little differently than most companies. Here's ...
  3. Fighting The High Costs Of Healthcare

    Fighting The High Costs Of Healthcare

    If your employer is cutting medical benefits, a health savings account may be right ...
  4. Concierge Healthcare: The Pros and Cons Of Having ...

    Concierge Healthcare: The Pros and Cons Of Having ...

    Concierge healthcare can mean extra attention from your doctor when you need it, ...
  5. Pharmaceutical Vs. Biotech Investing: Is It Worth ...

    Pharmaceutical Vs. Biotech Investing: Is It Worth ...

    Investopedia explains: Both pharma and biotech stocks are faced with a costly process ...
  6. Save On Visits To The Doctor

    Save On Visits To The Doctor

    There are situations where seeing a physician is more affordable than visiting a ...
  1. Overlooked Israel Is A Portfolio Growth Engine ...

    Overlooked Israel Is A Portfolio Growth Engine ...

    While it’s often overlooked, Israel could be one of the best destinations for your ...
  2. The Celtic Tiger Roars Once Again

    The Celtic Tiger Roars Once Again

    Everyone is Irish on St. Paddy’s Day. However, investors may want to keep that going ...
  3. The REIT Play In Healthcare

    The REIT Play In Healthcare

    At the end of the day, our population is aging quite rapidly and will require plenty ...
  4. Valeant Eyes Bausch & Lomb

    Valeant Eyes Bausch & Lomb

    Canadian pharmaceutical company Valeant has made a name for itself through acquisitions. ...
  5. Roche, Reloaded

    Roche, Reloaded

    Roche has one of the best long-term growth profiles in the Big Pharma space
  6. Elan Continues To Make Baffling Strategic Decision

    Elan Continues To Make Baffling Strategic Decision

    Elan seems to be set on wasting the Tysabri windfall instead of returning it to shareholders
Trading Center